Get started
Author

M. Q. Lacy

Observed names: Lacy, MQ, M Q Lacy, M. D. Martha Lacy, M. Lacy, M.Q. Lacy, Matha Q. Lacy
Institution: Mayo Clinic
OpenAlex ID: A5110162073
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
2006 · M A Elliott, A Tefferi, et al. · Bone Marrow Transplantation · 69
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
2013 · N. Leung, S. V. Glavey, et al. · Haematologica · 57
PDF
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
2016 · R Chakraborty, E Muchtar, et al. · Bone Marrow Transplantation · 32
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis
2008 · M. A. Gertz, M. Q. Lacy, et al. · Haematologica · 23
PDF
Pharmacodynamic properties of the anti-IGF-IR monoclonal antibody CP-751,871 in cancer patients
2007 · M. N. Pollak, M. Q. Lacy, et al. · Journal of Clinical Oncology · 12
Clinical and pathological phenotype of leukocyte cell-derived chemotaxin-2 (LECT2) amyloidosis (ALECT2)
2010 · Dogan, A, Theis, JD, et al. · UCL Discovery (University College London) · 10
Population pharmacokinetics of CP-751,871, a monoclonal antibody against IGF-I receptor, in patients with multiple myeloma or solid tumors
2008 · D. Yin, M. L. Paccagnella, et al. · Journal of Clinical Oncology · 8
Association of translocation t(11;14) with survival in patients with light chain (AL) amyloidosis
2008 · A. H. Bryce, R. Ketterling, et al. · Journal of Clinical Oncology · 3
Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a ‘graft versus host’-like syndrome and poor outcomes
2020 · Theodora Anagnostou, Reona Sakemura, et al. · Bone Marrow Transplantation · 2
Analysis of B Cell Clonal Evolution in BM and PBL of AL and MM Patients Using Graphical Quantification of Lineage Trees
2004 · R. S. Abraham, M. K. Manske, et al. · CRC Press eBooks · 2
Clinical Outcomes With and Without Sargramostim (GM-CSF) Post Autologous Peripheral Blood Stem Cell Transplantation
2009 · E.L. Howle, R.C. Wolf, et al. · Transplantation and Cellular Therapy · 1
PDF
P884: Potential Benefit of Post-transplant Doxycycline in Al Achieving Hematological Response After Autologous Stem Cell Transplant – Long Term Follow up
2022 · N. Abdallah, A. Dispenzieri, et al. · HemaSphere
Incidence of Cardiac Arrhythmias During Autologous Peripheral Blood Stem Cell Transplantation
2012 · A. Singla, W.H. Hogan, et al. · Transplantation and Cellular Therapy
Prognostic value of stringent complete response (sCR) post-autologous stem cell transplant (SCT) in multiple myeloma (MM)
2009 · P. Kapoor, S. Kumar, et al. · Journal of Clinical Oncology
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light chain amyloidosis
2008 · M. A. Gertz, M. Q. Lacy, et al. · Journal of Clinical Oncology
The Use of Sequential Living Donor Kidney and Autologous Stem Cell Transplantation for Patients with Primary (AL) Amyloidosis and Advanced Renal Failure
2004 · N. Leung, M. D. Griffin, et al. · CRC Press eBooks
Delayed Resolution of Nephrotic Syndrome Following Stem Cell Transplant for Amyloidosis (AL)
2004 · M. D. Morie Gertz, M. D. Nelson Leung, et al. · CRC Press eBooks
138Lymphocyte recovery after allogeneic stem cell transplantation: Comparison of bone marrow and peripheral blood stem cell transplantation
2003 · S. Kumar, I.N. Micallef, et al. · Transplantation and Cellular Therapy
PDF
Works count: 18
Citation count: 219
H-index: 7
I10-index: 6
Year
Topic
Type